alpha-aminopyridine has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cvetanovic, M; Johnson, A; Kim, JH; Lukowicz, A; Qu, W; Svedberg, D | 1 |
| Cheron, G; de Kerchove d'Exaerde, A; Gall, D; Hourez, R; Millard, I; Orduz, D; Orr, HT; Pandolfo, M; Schiffmann, SN; Servais, L | 1 |
2 other study(ies) available for alpha-aminopyridine and Autosomal Dominant Cerebellar Ataxia, Type II
| Article | Year |
|---|---|
Inhibition of colony-stimulating factor 1 receptor early in disease ameliorates motor deficits in SCA1 mice.
Topics: Aminopyridines; Animals; Ataxin-1; Calcium-Binding Proteins; Cerebellum; Disks Large Homolog 4 Protein; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Macrophage Colony-Stimulating Factor; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Motor Activity; Motor Disorders; Mutation; Neuroglia; Postural Balance; Pyrroles; Spinocerebellar Ataxias; Tumor Necrosis Factor-alpha; Vesicular Glutamate Transport Protein 2 | 2017 |
Aminopyridines correct early dysfunction and delay neurodegeneration in a mouse model of spinocerebellar ataxia type 1.
Topics: Action Potentials; Aminopyridines; Animals; Conditioning, Eyelid; Disease Models, Animal; Mice; Mice, Transgenic; Motor Skills Disorders; Nerve Degeneration; Neuroprotective Agents; Spinocerebellar Ataxias; Time Factors | 2011 |